Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

TherapeuticsMD, Inc. (TXMD) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

TherapeuticsMD, Inc. (TXMD), most recent 12 months reported: revenue $3.27M, net loss $217K. Latest balance sheet on file: liquid cash $9.19M. From SEC filings. Others in Pharmaceutical Preparations: CHINA PHARMA HOLDINGS, INC. · ProPhase Labs, Inc. · MARKER THERAPEUTICS, INC. · NRX Pharmaceuticals, Inc. · XENETIC BIOSCIENCES, INC. · Polomar Health Services, Inc. · UPSTREAM BIO, INC. · Connect Biopharma Holdings Limited

Stock screener

Watchlist